Ascletis Pharma (china) Co., Limited
Clinical trials sponsored by Ascletis Pharma (china) Co., Limited, explained in plain language.
-
New weight loss pill shows promise in Mid-Stage trial
Disease control CompletedThis study tested two versions of an experimental pill called ASC30 to see if it helps people with obesity or overweight lose weight. About 125 adults took either the real pill or a placebo (sugar pill) for 13 weeks. Researchers measured changes in body weight, waist size, and sa…
Phase: PHASE2 • Sponsor: Ascletis Pharma (China) Co., Limited • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Early test of potential new obesity treatment combination
Disease control CompletedThis early-stage study tested whether a new injection called ASC47 is safe when used alongside the established weight-loss medication semaglutide. It involved 28 adults with obesity to check for side effects and how the body processes the drug. The main goal was to gather initial…
Phase: PHASE1 • Sponsor: Ascletis Pharma (China) Co., Limited • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC